Fibromyalgia: a randomised, controlled trial of a treatment programme based on self management

C Cedraschi, J Desmeules, E Rapiti, E Baumgartner, P Cohen, A Finckh, A F Allaz, T L Vischer, C Cedraschi, J Desmeules, E Rapiti, E Baumgartner, P Cohen, A Finckh, A F Allaz, T L Vischer

Abstract

Objective: To evaluate the efficacy of a treatment programme for patients with fibromyalgia (FM) based on self management, using pool exercises and education.

Methods: Randomised controlled trial with a 6 month follow up to evaluate an outpatient multidisciplinary programme; 164 patients with FM were allocated to an immediate 6 week programme (n = 84) or to a waiting list control group (n = 80). The main outcomes were changes in quality of life, functional consequences, patient satisfaction and pain, using a combination of patient questionnaires and clinical examinations. The questionnaires included the Fibromyalgia Impact Questionnaire (FIQ), Psychological General Well-Being (PGWB) index, regional pain score diagrams, and patient satisfaction measures.

Results: 61 participants in the treatment group and 68 controls completed the programme and 6 month follow up examinations. Six months after programme completion, significant improvements in quality of life and functional consequences of FM were seen in the treatment group as compared with the controls and as measured by scores on both the FIQ (total score p = 0.025; fatigue p = 0.003; depression p = 0.031) and PGWB (total score p = 0.032; anxiety p = 0.011; vitality p = 0.013,). All four major areas of patient satisfaction showed greater improvement in the treatment than the control groups; between-group differences were statistically significant for "control of symptoms", "psychosocial factors", and "physical therapy" No change in pain was seen.

Conclusion: A 6 week self management based programme of pool exercises and education can improve the quality of life of patients with FM and their satisfaction with treatment. These improvements are sustained for at least 6 months after programme completion.

Figures

Figure 1
Figure 1
Flow diagram of the participants in the randomised trial.

References

    1. J Rheumatol. 2000 Dec;27(12):2727-30
    1. Arthritis Care Res. 1999 Apr;12(2):120-8
    1. Rheumatology (Oxford). 2001 Mar;40(3):348-9
    1. Arthritis Rheum. 2001 Feb;45(1):42-7
    1. Ann Intern Med. 2001 May 1;134(9 Pt 2):917-25
    1. Rheumatol Int. 2001 Apr;20(3):105-8
    1. Spine (Phila Pa 1976). 2001 Jul 1;26(13):1418-24
    1. Ann Rheum Dis. 2002 Jul;61(7):644-5
    1. J Rheumatol. 1987 Jun;14(3):446-51
    1. Arthritis Rheum. 1989 Apr;32(4):454-60
    1. J Rheumatol Suppl. 1989 Nov;19:12-4
    1. Arthritis Rheum. 1990 Feb;33(2):160-72
    1. Clin Exp Rheumatol. 1990 Sep-Oct;8(5):475-9
    1. Arthritis Care Res. 1990 Mar;3(1):11-8
    1. J Rheumatol. 1991 May;18(5):728-33
    1. Clin Rheumatol. 1991 Jun;10(2):168-73
    1. Clin J Pain. 1992 Jun;8(2):138-44
    1. BMJ. 1992 Nov 21;305(6864):1249-52
    1. J Rheumatol. 1993 Mar;20(3):475-9
    1. Qual Life Res. 1993 Dec;2(6):397-432
    1. J Rheumatol. 1994 Apr;21(4):714-20
    1. Baillieres Clin Rheumatol. 1994 Nov;8(4):935-55
    1. J Rheumatol. 1995 Jan;22(1):151-6
    1. Arthritis Care Res. 1994 Dec;7(4):221-5
    1. J Rheumatol. 1995 Feb;22(2):270-4
    1. Rheumatology (Oxford). 2000 Apr;39(4):343-6
    1. J Rheumatol. 2000 Oct;27(10):2473-81
    1. J Clin Epidemiol. 1995 Aug;48(8):1051-60
    1. Scand J Rheumatol. 1996;25(2):77-86
    1. J Rheumatol. 1996 Mar;23(3):521-8
    1. Scand J Rheumatol. 1996;25(5):300-6
    1. Am J Med Sci. 1998 Jun;315(6):397-404
    1. Arthritis Care Res. 1998 Apr;11(2):116-23
    1. Arthritis Care Res. 1998 Dec;11(6):432-47
    1. Ann Intern Med. 1999 Jun 1;130(11):910-21
    1. J Rheumatol. 2000 Dec;27(12):2801-9

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する